Shopping Cart
- Remove All
- Your shopping cart is currently empty
Xanthine oxidoreductase-IN-5 is an orally active inhibitor of xanthine oxidoreductase (XOR) with an IC50 of 55 nM. Xanthine oxidoreductase-IN-5 may be used in studies of acute hyperuricemia.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $36 | In Stock | |
5 mg | $84 | In Stock | |
10 mg | $139 | In Stock | |
25 mg | $233 | In Stock | |
50 mg | $329 | In Stock | |
100 mg | $482 | In Stock | |
200 mg | $687 | In Stock |
Description | Xanthine oxidoreductase-IN-5 is an orally active inhibitor of xanthine oxidoreductase (XOR) with an IC50 of 55 nM. Xanthine oxidoreductase-IN-5 may be used in studies of acute hyperuricemia. |
Targets&IC50 | Xanthine oxidoreductase:55 nM |
In vivo | Xanthine oxidoreductase-IN-5 (Compound IIIa) (5 mg/kg; oral) showed a lowering effect of uric acid in acute hyperuricemic mice at 5 h after administration.[1] |
Molecular Weight | 323.35 |
Formula | C17H17N5O2 |
Cas No. | 1026652-90-3 |
Smiles | C(NC1=CC=C(OC(C)C)C=C1)(=O)C2=CC=C(C=C2)C=3NN=NN3 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 45 mg/mL (139.17 mM), Sonication is recommended. ![]() | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.